Anzeige
❌
Mehr »
Freitag, 20.11.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
EL

WKN: A3D3BQ | ISIN: US28531P2020 | Ticker: 43E0
Frankfurt
20.11.26 | 08:03
4,180 Euro
-6,70 % -0,300
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
ELECTROCORE INC Chart 1 Jahr
5-Tage-Chart
ELECTROCORE INC 5-Tage-Chart

Aktuelle News zur ELECTROCORE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
12.11.electroCore, Inc.: Randomized Study of Non-Invasive Autonomic Neuromodulation for Long COVID Published Online in Neuromodulation1
05.11.ElectroCore outlines 30% to 40% 2027 revenue growth while targeting positive adjusted EBITDA by end of 20274
04.11.electroCore Q3 2026 Earnings Call Transcript1
ELECTROCORE Aktie jetzt für 0€ handeln
04.11.ElectroCore GAAP EPS of -$0.13 beats by $0.14, revenue of $9.7M misses by $1.23M1
04.11.electroCore, Inc. - 8-K, Current Report-
28.10.electroCore submits FDA 510(k) application for CIPN device1
18.09.Full Transcript: electroCore Q2 2026 Earnings Call1
09.09.electroCore appoints Joshua Lev and Mike Fox as co-CEOs4
09.09.electroCore, Inc. - 8-K, Current Report3
25.08.electroCore, Inc.: electroCore's Truvaga Named Best Luxury Biohacking & Longevity Brand in the USA by Luxury Lifestyle Awards3
07.08.ElectroCore targets positive adjusted EBITDA in Q3 2027 while lifting 2026 revenue growth outlook to greater than 30%3
16.07.electroCore, Inc.: New Review Examines Anatomical and Methodological Differences Between Auricular and Cervical Vagus Nerve Stimulation2
09.06.electroCore, Inc.: Frontiers in Neuroscience Accepts Review Article Synthesizing Evidence that Cervical nVNS Activates the Vagus Nerve Without Surgery1
02.06.electroCore, Inc.: electroCore to Present at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClub1
19.03.electroCore, Inc.: electroCore Announces Full Year 2025 Financial Results and Organizational Changes667Record full year 2025 net sales of $32.0, an increase of 27% over $25.2 million for the full year 2024 driven by 25% annual growth in our U.S. prescription business and 97% increase in general wellness...
► Artikel lesen
20.01.electroCore, Inc.: electroCore Provides Preliminary Full-Year 2025 Business Update; Expects ~26% Revenue Growth to ~$31.8-$32.0 Million244Record revenue of approximately $31.8 - $32.0 million for full-year 2025 and approximately $9.0 - $9.2 million for the three months ended December 31, 2025 Revenue growth of approximately 26% over...
► Artikel lesen
16 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1